ENT & Bronchoscopy Market - Forecast(2024 - 2030)

Report Code: HCR 0852 Report Format: PDF + Excel

ENT & Bronchoscopy Market Overview

ENT & Bronchoscopy Market size is estimated to reach $62.4 billion by 2027, growing at a CAGR of 7.8% during the forecast period 2022-2027. ENT specialists treat a distinct series of conditions and ailments of the ears, nose, throat, head, and neck region—from simple to serious, for all people, at all phases of life. A bronchoscopy is a medical test that allows physicians to observe the lungs and airways utilizing a thin tube with a camera and light at the end. It is normally carried out by a physician who specializes in lung ailments and is called a pulmonologist. A rigid bronchoscope is a straight, metal, lighted tube suited to envision the large airways with ventilatory capacity by way of the related ventilating side port. All hearing aids utilize the identical fundamental parts to bear sounds from the environment into the ear and make them louder. Nearly all hearing aids are digital, and all are powered with a conventional hearing aid battery or a rechargeable battery. Flexible bronchoscopes are built of thousands of glass fibers that bear the image (certain implements have a video chip at the tip to produce the image) and brilliance, and their distal tips can be angulated to aim the implement into the appropriate anatomic location. Olympus provides a flexible selection of cytology brushes to fit the requirements of particular clinical needs. All brushes are outfitted with a metal tip that permits ideal visibility under fluoroscopy and an atraumatic brushing process. With their fine micro bristles, they were confirmed to accumulate considerably more cells in comparison with standard bristles with superior diagnostic outcomes. If one has been diagnosed with lung cancer (or initial tests are strongly indicative of it), endobronchial ultrasound may be arranged at the side of conventional bronchoscopy. Hearing care devices are utilized to enhance or restore hearing in individuals enduring temporary or permanent hearing loss. Medtronic has developed an image-guided surgery system termed fusion system Whether it is for Functional Endoscopic Sinus Surgery (FESS) or skull base procedures, image-guided surgery with the Fusion™ ENT Navigation System can assist surgeons to make more cognizant decisions in the OR. Image-guided surgery offers the maximum quantity of information about every patient's rare anatomy for more secure, more all-encompassing mechanics. Nasal splints are thought-out to be imminent for nearly all nasal surgeries. It has a significant role in the recovery period of patients subsequent to their surgery.

The increasing pervasiveness of hearing and nasal ailments which may require the application of nasal splints and novel technological progress in ENT and Bronchoscopy devices are set to drive the ENT & Bronchoscopy Market. The expanding population of the elderly and the boost in inclination of patients toward minimally invasive procedures are set to propel the growth of the ENT & Bronchoscopy Market during the forecast period 2022-2027. This represents the ENT And Bronchoscopy Industry Outlook.

Report Coverage

The report: ENT & Bronchoscopy Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the ENT & Bronchoscopy Market.

By Product Type: Endoscopes, Surgical ENT & Bronchoscopy Devices, Hearing Care Devices.
By End User: Hospitals & Clinics, Home Use, Ambulatory Surgical Centers (ASCs).
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America ENT & Bronchoscopy Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the surging awareness regarding the benefits of utilizing ENT devices solutions including hearing aids and the proliferating count of bronchoscopy procedures in the North American region.
  • ENT & Bronchoscopy Market growth is being driven by the increasing predominance of ear, nose, and throat (ENT) related ailments possibly requiring the application of devices like hearing aids and a rise in the count of cases associated with respiratory ailments. However, the soaring cost of these devices specifically in the developing countries, and the lack of skilled professionals are some of the major factors hampering the growth of the ENT & Bronchoscopy Market. 
  • ENT & Bronchoscopy Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the ENT & Bronchoscopy Market report

ENT & Bronchoscopy Market: Market Share (%) by Region, 2021

For More Details on This Report - Request for Sample

ENT & Bronchoscopy Market Segment Analysis – By Product Type:

The ENT & Bronchoscopy Market based on product type can be further segmented into Endoscopes, Surgical ENT & Bronchoscopy Devices, and Hearing Care Devices. The Hearing Care Devices Segment held the largest market share in 2021. This growth is owing to the increasing pervasiveness of hearing ailments worldwide. Hearing aids and hearing aid apps are typically recommended for patients with hearing loss. The soaring technological innovations including the development of auditory brainstem implants are further propelling the growth of the Hearing Care Devices segment.

Furthermore, the Surgical ENT & Bronchoscopy Devices segment is estimated to grow with the fastest CAGR of 8.7% during the forecast period 2022-2027 owing to the proliferating and novel technological progress in ENT and Bronchoscopy devices with internal nasal splints being recommended in case of surgeries like septoplasty.

ENT & Bronchoscopy Market Segment Analysis – By End User:

The ENT & Bronchoscopy Market based on end user can be further segmented into Hospitals & Clinics, Home Use, and Ambulatory Surgical Centers (ASCs). The Hospitals segment held the largest market share in 2021. This growth is owing to the effortless accessibility of progressive infrastructure pertaining to ENT and Bronchoscopy treatment in hospitals. Flexible bronchoscopes are frequently utilized in the intensive care unit for fiberoptic intubation, therapeutic aspiration, foreign body removal, percutaneous tracheostomy placement, and handling massive hemoptysis. The easy availability of specialists and the enormous count of patients visiting hospitals are further propelling the growth of this segment.

Furthermore, the Ambulatory Surgical Centers (ASCs) segment is estimated to grow with the fastest CAGR of 8.6% during the forecast period 2022-2027 owing to the surging count of outpatient surgeries performed at ambulatory surgical centers pertaining to otolaryngology which deals with ailments of the ear and throat with hearing aids being recommended for patients with hearing loss. 

ENT & Bronchoscopy Market Segment Analysis – By Geography:

The ENT & Bronchoscopy Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and Rest of the World. North America (ENT & Bronchoscopy Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the existence of key players like Stryker Corporation in the North American region. Internal nasal splints may be recommended in the case of surgeries like septoplasty.   The increasing predominance of respiratory ailments is further propelling the growth of the ENT & Bronchoscopy Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the existence of many market players and the accessibility of progressive technology in the Asia-Pacific region. The supportive government initiatives and programs, proliferating application of hearing aids and nasal splints, and the increasing predominance of incessant pulmonary ailments like asthma in countries like India are further fuelling the progress of the ENT Bronchoscopy Market in the Asia-Pacific region.

ENT & Bronchoscopy Market - Drivers

Surging Applications Of Hearing Aid Apps And Nasal Splints Are Projected To Drive The Growth Of ENT & Bronchoscopy Market:

Certain quick statistics regarding hearing indicate that around 28.8 million U.S. mature grown-ups could be helped by utilizing hearing aids and among mature grown-ups aged 70 and older with hearing loss who could gain from hearing aids, lesser than one in three (30 percent) has ever utilized them. Rather than making contact with the hearing aids to press a button, some taps may be carefully made on a cell phone. People around will not be able to make out if hearing and settings are being altered unless they observe the screen of the smartphone. It will appear as if one is inspecting his/her email or the weather report. Hearing aid apps offer numerous functions. The complete level of the sound can be altered with volume control. The sound is distinct bands that can be adapted with an equalizer. The noise reduction and directionality settings can be adapted within a program. The listening program utilized may be altered. Accessories like television streaming devices may be connected.  Nasal splints serve as a cast for the nose subsequent to surgery. They disarm the nose and assist in maintaining its novel shape subsequent to some surgical procedures. Septoplasty is carried out on the septum, or piece of cartilage between the nostrils. A surgeon who carries out septoplasty straightens the septum as much as possible so that one can breathe properly through his/her nose. After this kind of surgery, one normally requires internal nasal splints to maintain the septum in place as it heals. Nasal splints may be required after surgeries pertaining to Rhinoseptoplasty and Rhinoplasty. The surging applications of hearing aid apps and nasal splints are therefore fuelling the growth of the ENT & Bronchoscopy Market during the forecast period 2022-2027.

Proliferating Applications Of Flexible Bronchoscopes Are Expected To Boost The Demand For ENT And Bronchoscopy:

Flexible bronchoscopy serves a crucial role in diagnostic and therapeutic interventions for an assortment of pulmonary ailments. Diagnostic applications involve airway inspection and sampling of endobronchial lesions, bronchoalveolar lavage (BAL), brushings, and lung biopsies. Flexible bronchoscopy is typically utilized for lung cancer diagnosis and mediastinal staging using endobronchial ultrasound. Therapeutic applications involve aspiration of mucoid or hemorrhagic secretions, endobronchial valve placement (for persistent air leak and bronchoscopic lung volume reduction), thermal ablative therapy, cryotherapy, tumor debulking, foreign body retrieval, airway stent deployment, guidance for percutaneous tracheostomy placement, and fiducial marker placement before lung resection. The application of peracetic acid (PAA) is suggested for the disinfection of flexible bronchoscopes with a contact time of 5 min. It is suggested that a 70% alcohol purge be carried out as the final step of bronchoscope disinfection. In the setting of the continuing COVID-19 pandemic, single-use flexible bronchoscopes (SUFB) have amassed attention owing to different professional pulmonary societies having discharged guidelines regarding applications for SUFB given the concern for risk of viral transmission when utilizing reusable flexible bronchoscopes (RFB). The proliferating applications of flexible bronchoscopes are therefore driving the growth of the ENT & Bronchoscopy Market during the forecast period 2022-2027.

ENT & Bronchoscopy Market – Challenges

Complexities Of Bronchoscopy Are Hampering The Growth Of The ENT & Bronchoscopy Market:

Since its presentation in the 1960s, published rates of complication from fiberoptic bronchoscopy have ranged from <0.1 to 11%, with mortality typically recorded between 0 and 0.1%. Mechanical complications of fiberoptic bronchoscopy involve oro- or nasopharyngeal, vocal cord, and airway trauma as well as bronchospasm, laryngospasm, pulmonary derecruitment/atelectasis, pneumothorax, airway hemorrhage, and presentation or exacerbation of infection. Typically, the rates of mechanical complications have been, and persist to be, quite low. The most constantly recorded mechanical complications are associated with airway manipulation/trauma and bleeding. Systemic complications are principally associated with the procedure itself, medication administration, or patient comorbidities. Systemic complications associated with the procedure involved vasovagal syncope, nausea/vomiting, aspiration, and hypoxemia. These issues are thus hampering the growth of the ENT & Bronchoscopy Market.

ENT And Bronchoscopy Industry Outlook:

Product launches, collaborations, mergers and acquisitions, partnerships, joint ventures and R&D activities are key strategies adopted by players in the ENT & Bronchoscopy Market. Key companies of this market are:

  1. Cochlear Ltd.
  2. Medtronic PLC.
  3. Olympus Corporation
  4. Stryker Corporation
  5. Sivantos Group
  6. Teleflex Inc.
  7. Karl Storz GmbH
  8. Fujifilm Holdings Corporation
  9. Ambu A/S
  10. Smith Nephew Plc.

Recent Developments

  • In January 2022, Medtronic plc declared that it has got into a definitive agreement to gain Affera, Inc., a Boston area-based, privately held medical technology firm. Affera plans and produces cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, involving a differentiated, focal pulsed-field ablation solution, for the treatment of patients with cardiac arrhythmias (irregular heartbeats) like atrial fibrillation (AF). Medtronic, by way of its minority investment portfolio, has been a strategic investor in Affera and presently holds a 3% ownership stake in the firm.
  • In August 2021, Medtronic plc declared that it has got into a definitive agreement with Intersect ENT, a global ear, nose, and throat (ENT) medical technology leader committed to transforming patient care, in which Medtronic will gain all outstanding shares of Intersect ENT for $28.25 per share in an all-cash transaction hinting an enterprise value of nearly $1.1 billion. The boards of directors of both firms have unitedly endorsed the transaction. Medtronic's gain of Intersect ENT extends the firm's portfolio of products utilized at the time of ear, nose, and throat procedures.
  • In December 2020, Olympus Corporation declared that it has got into an agreement to gain Veran Medical Technologies, Inc. (“VMT”), a leading provider of progressive medical devices specializing in interventional pulmonology, for up to USD 340 million. The gain will be implemented by way of Olympus subsidiary Olympus Corporation of the Americas (“OCA”) and will be the most recent in a range of strategic acquisitions planned to reinforce Olympus’ position as a leading global medical device firm. As a portion of Olympus’ Corporate Strategy, revealed in November 2019, the firm promised to “focus and scale” its therapeutic solutions division.

Related Reports-

ENT And Bronchoscopy Devices Market -  Forecast 2021 – 2026

Report Code: HCR 70766

Endoscopic Camera System Market – Forecast (2022 - 2027)

Report Code: ESR 0303

ENT Devices Market – Forecast (2022 - 2027)

Report Code: HCR 0569 

For more Lifesciences and Healthcare Market reports, please click here

1. ENT & Bronchoscopy Market Overview
    1.1 Definitions and Scope
2. ENT & Bronchoscopy Market- Executive Summary
3. ENT & Bronchoscopy Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. ENT & Bronchoscopy Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. ENT & Bronchoscopy Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. ENT & Bronchoscopy Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. ENT & Bronchoscopy Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. ENT & Bronchoscopy Market  – By Product Type (Market Size –$Million/$Billion) 
    8.1 Endoscopes
    8.2 Surgical ENT & Bronchoscopy Devices
    8.3 Hearing Care Devices
9. ENT & Bronchoscopy Market  - By End User (Market Size –$Million/$Billion) 
    9.1 Hospitals & Clinics
    9.2 Home Use
    9.3 Ambulatory Surgical Centers (ASCs)
10. ENT & Bronchoscopy Market  - By Geography (Market Size -$Million/Billion)
    10.1 North America
        10.1.1 U.S
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 Germany
        10.2.2 France
        10.2.3 UK
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Chile
        10.4.4 Colombia
        10.4.5 Rest of South America
    10.5 Rest Of The World
        10.5.1 Middle East
        10.5.2 Africa
11. ENT & Bronchoscopy Market - Market Entropy
    11.1 New product launches
    11.2 M&A's, collaborations, JVs and partnerships
12. ENT & Bronchoscopy Market – Industry Competition Landscape (Premium)
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key Companies
        12.1.3 Market Share by Countries – Key Companies
    12.2 Competition Matrix
    12.3 Best Practices for Companies
13. ENT & Bronchoscopy Market  – Key Company List by Country Premium (Premium)
14. ENT & Bronchoscopy Market - Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"